STOCK TITAN

[Form 4] Calumet, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 08/05/2025, Calumet, Inc. (CLMT) director Amy M. Schumacher filed a Form 4 reporting receipt of 1,965 Restricted Stock Units (RSUs).

  • 1,474 RSUs are already 100 % vested and will be settled in common stock upon the earlier of a date chosen by Schumacher or her separation from the company.
  • 491 RSUs were issued under Calumet’s Deferred Compensation Plan; 25 % of this tranche vests each 1 July beginning 2026, with settlement timing identical to the first grant.

Both grants were acquired at $0.00 cost, involve no share sales and remain under direct ownership. The transaction increases Schumacher’s derivative holdings to 1,965 RSUs but does not change the public float or generate immediate cash-flow or earnings impact. While routine, the equity award reinforces long-term alignment between the director and shareholders.

Il 08/05/2025, Amy M. Schumacher, direttrice di Calumet, Inc. (CLMT), ha presentato un Modulo 4 segnalando la ricezione di 1.965 Unità Azionarie Vincolate (RSU).

  • 1.474 RSU sono già completamente maturate e saranno convertite in azioni ordinarie alla data scelta da Schumacher o al momento della sua separazione dall'azienda, a seconda di quale evento si verifichi per primo.
  • 491 RSU sono state assegnate nell'ambito del Piano di Compensazione Differita di Calumet; il 25% di questa tranche matura ogni 1° luglio a partire dal 2026, con tempistiche di conversione identiche alla prima assegnazione.

Entrambe le assegnazioni sono state ottenute a costo $0,00, non prevedono vendite di azioni e rimangono sotto proprietà diretta. Questa operazione incrementa il possesso di strumenti derivati di Schumacher a 1.965 RSU, senza però modificare il flottante pubblico né generare un impatto immediato su flussi di cassa o utili. Pur essendo una prassi abituale, questo premio azionario rafforza l'allineamento a lungo termine tra la direttrice e gli azionisti.

El 08/05/2025, Amy M. Schumacher, directora de Calumet, Inc. (CLMT), presentó un Formulario 4 notificando la recepción de 1.965 Unidades de Acciones Restringidas (RSU).

  • 1.474 RSU ya están 100 % adquiridas y se liquidarán en acciones ordinarias en la fecha que Schumacher elija o al momento de su separación de la empresa, lo que ocurra primero.
  • 491 RSU fueron emitidas bajo el Plan de Compensación Diferida de Calumet; el 25 % de este tramo se adquiere cada 1 de julio a partir de 2026, con el mismo calendario de liquidación que la primera concesión.

Ambas concesiones se adquirieron sin costo ($0.00), no implican ventas de acciones y permanecen bajo propiedad directa. La transacción incrementa las participaciones derivadas de Schumacher a 1.965 RSU, pero no altera el flotante público ni genera un impacto inmediato en flujo de caja o ganancias. Aunque es una operación rutinaria, la concesión de acciones refuerza la alineación a largo plazo entre la directora y los accionistas.

2025년 8월 5일, Calumet, Inc.(CLMT) 이사 Amy M. Schumacher1,965개의 제한 주식 단위(RSU) 수령을 보고하는 양식 4를 제출했습니다.

  • 1,474 RSU는 이미 100% 완전 귀속되었으며, Schumacher가 선택한 날짜 또는 회사에서 퇴사하는 날짜 중 빠른 시점에 보통주로 정산됩니다.
  • 491 RSU는 Calumet의 이연 보상 계획에 따라 발행되었으며, 이 트랜치의 25%는 2026년 7월 1일부터 매년 귀속되며, 정산 시기는 첫 번째 부여와 동일합니다.

두 부여 모두 $0.00의 비용으로 취득되었으며, 주식 매도 없이 직접 소유 상태로 유지됩니다. 이번 거래로 Schumacher의 파생 상품 보유량은 1,965 RSU로 증가하지만, 유통 주식 수에는 변화가 없고 즉각적인 현금 흐름이나 수익 영향도 없습니다. 일상적인 절차이지만, 이번 주식 부여는 이사와 주주 간의 장기적인 이해관계 일치를 강화합니다.

Le 08/05/2025, Amy M. Schumacher, administratrice de Calumet, Inc. (CLMT), a déposé un formulaire 4 déclarant la réception de 1 965 unités d’actions restreintes (RSU).

  • 1 474 RSU sont déjà entièrement acquises et seront réglées en actions ordinaires à la date choisie par Schumacher ou à la date de son départ de l’entreprise, selon le premier événement.
  • 491 RSU ont été émises dans le cadre du Plan de Rémunération Différée de Calumet ; 25 % de cette tranche acquièrent droit chaque 1er juillet à partir de 2026, avec un calendrier de règlement identique à la première attribution.

Les deux attributions ont été obtenues à un coût de 0,00 $, n’impliquent aucune vente d’actions et restent sous propriété directe. Cette opération augmente la détention dérivée de Schumacher à 1 965 RSU, sans modifier le flottant public ni générer d’impact immédiat sur les flux de trésorerie ou les résultats. Bien que routinière, cette attribution d’actions renforce l’alignement à long terme entre l’administratrice et les actionnaires.

Am 08.05.2025 meldete Amy M. Schumacher, Direktorin von Calumet, Inc. (CLMT), mittels Formular 4 den Erhalt von 1.965 Restricted Stock Units (RSUs).

  • 1.474 RSUs sind bereits vollständig unverfallbar und werden in Stammaktien umgewandelt, entweder zu einem von Schumacher gewählten Datum oder bei ihrem Ausscheiden aus dem Unternehmen, je nachdem, was zuerst eintritt.
  • 491 RSUs wurden im Rahmen von Calumets Deferred Compensation Plan ausgegeben; jeweils 25 % dieses Tranchenanteils verfallen jährlich zum 1. Juli ab 2026, mit identischem Abwicklungszeitpunkt wie bei der ersten Zuteilung.

Beide Zuteilungen wurden zu einem Preis von $0,00 erworben, beinhalten keinen Aktienverkauf und verbleiben im direkten Eigentum. Die Transaktion erhöht Schumachers derivative Beteiligungen auf 1.965 RSUs, verändert jedoch weder den Streubesitz noch hat sie unmittelbare Auswirkungen auf Cashflow oder Gewinn. Obwohl routinemäßig, stärkt die Aktienzuteilung die langfristige Ausrichtung zwischen der Direktorin und den Aktionären.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine RSU award; negligible market impact.

The filing shows a non-cash equity grant to Director Schumacher—1,965 RSUs at zero cost. Because no shares were sold or purchased on the open market, the transaction neither signals bullish insider buying nor bearish selling. Dilution is immaterial given Calumet’s ~80 m outstanding units. Expense recognition was likely accrued under existing compensation plans, so no new P&L effect arises. Overall, the event is governance-related, not valuation-moving.

TL;DR: Standard board compensation; aligns incentives.

The RSUs are in line with typical director pay structures, split between fully-vested and deferred units to encourage retention. Immediate vesting of the larger block suggests prior service, whereas the staggered vesting on the 491 RSUs fosters continued engagement through 2029. No 10b5-1 plan was noted, and ownership remains direct, providing clear accountability. Governance impact is neutral-to-slightly positive, but not material for investors.

Il 08/05/2025, Amy M. Schumacher, direttrice di Calumet, Inc. (CLMT), ha presentato un Modulo 4 segnalando la ricezione di 1.965 Unità Azionarie Vincolate (RSU).

  • 1.474 RSU sono già completamente maturate e saranno convertite in azioni ordinarie alla data scelta da Schumacher o al momento della sua separazione dall'azienda, a seconda di quale evento si verifichi per primo.
  • 491 RSU sono state assegnate nell'ambito del Piano di Compensazione Differita di Calumet; il 25% di questa tranche matura ogni 1° luglio a partire dal 2026, con tempistiche di conversione identiche alla prima assegnazione.

Entrambe le assegnazioni sono state ottenute a costo $0,00, non prevedono vendite di azioni e rimangono sotto proprietà diretta. Questa operazione incrementa il possesso di strumenti derivati di Schumacher a 1.965 RSU, senza però modificare il flottante pubblico né generare un impatto immediato su flussi di cassa o utili. Pur essendo una prassi abituale, questo premio azionario rafforza l'allineamento a lungo termine tra la direttrice e gli azionisti.

El 08/05/2025, Amy M. Schumacher, directora de Calumet, Inc. (CLMT), presentó un Formulario 4 notificando la recepción de 1.965 Unidades de Acciones Restringidas (RSU).

  • 1.474 RSU ya están 100 % adquiridas y se liquidarán en acciones ordinarias en la fecha que Schumacher elija o al momento de su separación de la empresa, lo que ocurra primero.
  • 491 RSU fueron emitidas bajo el Plan de Compensación Diferida de Calumet; el 25 % de este tramo se adquiere cada 1 de julio a partir de 2026, con el mismo calendario de liquidación que la primera concesión.

Ambas concesiones se adquirieron sin costo ($0.00), no implican ventas de acciones y permanecen bajo propiedad directa. La transacción incrementa las participaciones derivadas de Schumacher a 1.965 RSU, pero no altera el flotante público ni genera un impacto inmediato en flujo de caja o ganancias. Aunque es una operación rutinaria, la concesión de acciones refuerza la alineación a largo plazo entre la directora y los accionistas.

2025년 8월 5일, Calumet, Inc.(CLMT) 이사 Amy M. Schumacher1,965개의 제한 주식 단위(RSU) 수령을 보고하는 양식 4를 제출했습니다.

  • 1,474 RSU는 이미 100% 완전 귀속되었으며, Schumacher가 선택한 날짜 또는 회사에서 퇴사하는 날짜 중 빠른 시점에 보통주로 정산됩니다.
  • 491 RSU는 Calumet의 이연 보상 계획에 따라 발행되었으며, 이 트랜치의 25%는 2026년 7월 1일부터 매년 귀속되며, 정산 시기는 첫 번째 부여와 동일합니다.

두 부여 모두 $0.00의 비용으로 취득되었으며, 주식 매도 없이 직접 소유 상태로 유지됩니다. 이번 거래로 Schumacher의 파생 상품 보유량은 1,965 RSU로 증가하지만, 유통 주식 수에는 변화가 없고 즉각적인 현금 흐름이나 수익 영향도 없습니다. 일상적인 절차이지만, 이번 주식 부여는 이사와 주주 간의 장기적인 이해관계 일치를 강화합니다.

Le 08/05/2025, Amy M. Schumacher, administratrice de Calumet, Inc. (CLMT), a déposé un formulaire 4 déclarant la réception de 1 965 unités d’actions restreintes (RSU).

  • 1 474 RSU sont déjà entièrement acquises et seront réglées en actions ordinaires à la date choisie par Schumacher ou à la date de son départ de l’entreprise, selon le premier événement.
  • 491 RSU ont été émises dans le cadre du Plan de Rémunération Différée de Calumet ; 25 % de cette tranche acquièrent droit chaque 1er juillet à partir de 2026, avec un calendrier de règlement identique à la première attribution.

Les deux attributions ont été obtenues à un coût de 0,00 $, n’impliquent aucune vente d’actions et restent sous propriété directe. Cette opération augmente la détention dérivée de Schumacher à 1 965 RSU, sans modifier le flottant public ni générer d’impact immédiat sur les flux de trésorerie ou les résultats. Bien que routinière, cette attribution d’actions renforce l’alignement à long terme entre l’administratrice et les actionnaires.

Am 08.05.2025 meldete Amy M. Schumacher, Direktorin von Calumet, Inc. (CLMT), mittels Formular 4 den Erhalt von 1.965 Restricted Stock Units (RSUs).

  • 1.474 RSUs sind bereits vollständig unverfallbar und werden in Stammaktien umgewandelt, entweder zu einem von Schumacher gewählten Datum oder bei ihrem Ausscheiden aus dem Unternehmen, je nachdem, was zuerst eintritt.
  • 491 RSUs wurden im Rahmen von Calumets Deferred Compensation Plan ausgegeben; jeweils 25 % dieses Tranchenanteils verfallen jährlich zum 1. Juli ab 2026, mit identischem Abwicklungszeitpunkt wie bei der ersten Zuteilung.

Beide Zuteilungen wurden zu einem Preis von $0,00 erworben, beinhalten keinen Aktienverkauf und verbleiben im direkten Eigentum. Die Transaktion erhöht Schumachers derivative Beteiligungen auf 1.965 RSUs, verändert jedoch weder den Streubesitz noch hat sie unmittelbare Auswirkungen auf Cashflow oder Gewinn. Obwohl routinemäßig, stärkt die Aktienzuteilung die langfristige Ausrichtung zwischen der Direktorin und den Aktionären.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schumacher Amy M

(Last) (First) (Middle)
1060 N CAPITOL AVE
SUITE 6-401

(Street)
INDIANAPOLIS IN 46204

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Calumet, Inc. /DE [ CLMT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 08/05/2025 A 1,474 (2) (2) Common Stock, par value $0.01 per share 1,474 $0 1,474 D
Restricted Stock Units (1) 08/05/2025 A 491 (3) (3) Common Stock, par value $0.01 per share 491 $0 491 D
Explanation of Responses:
1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
2. Each Restricted Stock Unit will become settled upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested.
3. Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2026.
/s/ Connor J. Egan, as attorney-in-fact 08/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many RSUs did CLMT director Amy Schumacher receive in the 08/05/2025 Form 4?

She was awarded 1,965 RSUs (1,474 fully-vested plus 491 deferred units).

Were any Calumet (CLMT) shares sold or purchased on the open market?

No. The filing discloses only RSU grants; there were no open-market transactions.

When do the newly granted RSUs vest?

The 1,474-unit block is 100 % vested; the 491-unit block vests 25 % each July 1 starting 2026.

What is the transaction date reported in the Form 4?

The RSU grants were effective on 08/05/2025.

Does the RSU grant affect Calumet’s earnings or cash flow?

It is a non-cash, equity-based expense; no immediate cash-flow impact and any expense is already accounted for under compensation plans.
Calumet

NASDAQ:CLMT

CLMT Rankings

CLMT Latest News

CLMT Latest SEC Filings

CLMT Stock Data

1.32B
67.50M
22.1%
47.39%
10.5%
Specialty Chemicals
Petroleum Refining
Link
United States
INDIANAPOLIS